Wed, February 24, 2021
Tue, February 23, 2021
Mon, February 22, 2021

Charles Duncan Reiterated (AVXL) at Buy with Increased Target to $25 on, Feb 23rd, 2021

Charles Duncan of Cantor Fitzgerald, Reiterated "Anavex Life Sciences Corp." (AVXL) at Buy with Increased Target from $10 to $25 on, Feb 23rd, 2021.

Charles has made no other calls on AVXL in the last 4 months.



There is 1 other peer that has a rating on AVXL. Out of the 1 peers that are also analyzing AVXL, 0 agree with Charles's Rating of Hold.



This is the rating of the analyst that currently disagrees with Charles


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $17 on, Wednesday, December 16th, 2020